photo of

Details

Role Director
Group Director's Office
Professor Kathryn North AC BSc(Med) MBBS MD DMedSc FRACP FAHMS

Professor Kathryn North AC is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.

Professor North is trained as a physician, neurologist and clinical geneticist and in 1994, was awarded a doctorate for research in neurogenetics. She completed a postdoctoral fellowship in the Harvard Genetics Program.

Professor North is a national and international leader in Genomic medicine. In 2014, Professor North was appointed as Co-Chair of the Global Alliance for Genomics and Health - a collaborative network of over 500 organisations across over 100 countries funded by the NIH and the Wellcome Trust (genomicsandhealth.org). Commencing in 2016, she leads an NHMRC-funded national network of over 80 institutions - the Australian Genomics Health Alliance (AGHA). The goal of AGHA is to provide evidence and practical strategies for the implementation of genomic medicine in the Australian health system.

Professor North chaired the National Health and Medical Research Council Research Committee from 2012-2018, and has chaired the International Advisory Board of the Great Ormond Street Institute of Child Health (UK) since 2015. She is a member of the Board of the Victorian Comprehensive Cancer Centre. In 2014, she was appointed as a Foundation fellow of the Australian Academy of Health and Medical Science, and in 2020 joined the Academy’s Board. In 2020, she joined the Board of the Association of Australian Medical Research Institutes (AAMRI) as President-Elect.

Professor North has received a number of awards including the GSK Australia Award for Research Excellence (2011), the Ramaciotti Medal for Excellence in Biomedical Research (2012) and Member of the Order of Australia (AM) for service to medicine in the field of neuromuscular and neurogenetics research (2012). In 2019, Professor North was appointed a Companion of the Order of Australia (AC), for eminent service to genomic medicine internationally, to medical research in the field nationally and of genetics, neurology and child health, and as a mentor and role model.
Professor Kathryn North AC BSc(Med) MBBS MD DMedSc FRACP FAHMS

Professor Kathryn North AC is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.

Professor...
Professor Kathryn North AC BSc(Med) MBBS MD DMedSc FRACP FAHMS

Professor Kathryn North AC is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.

Professor North is trained as a physician, neurologist and clinical geneticist and in 1994, was awarded a doctorate for research in neurogenetics. She completed a postdoctoral fellowship in the Harvard Genetics Program.

Professor North is a national and international leader in Genomic medicine. In 2014, Professor North was appointed as Co-Chair of the Global Alliance for Genomics and Health - a collaborative network of over 500 organisations across over 100 countries funded by the NIH and the Wellcome Trust (genomicsandhealth.org). Commencing in 2016, she leads an NHMRC-funded national network of over 80 institutions - the Australian Genomics Health Alliance (AGHA). The goal of AGHA is to provide evidence and practical strategies for the implementation of genomic medicine in the Australian health system.

Professor North chaired the National Health and Medical Research Council Research Committee from 2012-2018, and has chaired the International Advisory Board of the Great Ormond Street Institute of Child Health (UK) since 2015. She is a member of the Board of the Victorian Comprehensive Cancer Centre. In 2014, she was appointed as a Foundation fellow of the Australian Academy of Health and Medical Science, and in 2020 joined the Academy’s Board. In 2020, she joined the Board of the Association of Australian Medical Research Institutes (AAMRI) as President-Elect.

Professor North has received a number of awards including the GSK Australia Award for Research Excellence (2011), the Ramaciotti Medal for Excellence in Biomedical Research (2012) and Member of the Order of Australia (AM) for service to medicine in the field of neuromuscular and neurogenetics research (2012). In 2019, Professor North was appointed a Companion of the Order of Australia (AC), for eminent service to genomic medicine internationally, to medical research in the field nationally and of genetics, neurology and child health, and as a mentor and role model.

Top Publications

  • Payne, JM, Walsh, KS, Pride, NA, Haebich, KM, Maier, A, Chisholm, A, Glad, DM, Casnar, CL, Rouel, M, Lorenzo, J, et al. Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes. Developmental Medicine & Child Neurology 62(7) : 813 -819 2020
    view publication
  • Knights, AJ, Vohralik, EJ, Houweling, PJ, Stout, ES, Norton, LJ, Alexopoulos, SJ, Yik, JJ, Mat Jusoh, H, Olzomer, EM, Bell-Anderson, KS, et al. Eosinophil function in adipose tissue is regulated by Krüppel-like factor 3 (KLF3).. Nat Commun 11(1) : 2922 2020
    view publication
  • Spitali, P, Zaharieva, I, Bohringer, S, Hiller, M, Chaouch, A, Roos, A, Scotton, C, Claustres, M, Bello, L, McDonald, CM, et al. TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy. European Journal of Human Genetics 28(6) : 815 -825 2020
    view publication
  • Kiriaev, L, Kueh, S, Morley, JW, North, KN, Houweling, PJ, Head, SI. Isolated extensor digitorum longus muscles from old mdx dystrophic mice show little force recovery 120 minutes after eccentric damage. The FASEB Journal 34(S1) : 1 -1 2020
    view publication
  • Ullrich, NJ, Payne, JM, Walsh, KS, Cutter, G, Packer, R, North, K, Rey‐Casserly, C, Consortium, TNCT. Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1. Annals of Clinical and Translational Neurology 7(2) : 245 -249 2020
    view publication